| Current Price | $23.28 | Mkt Cap | $1.98B |
|---|---|---|---|
| Open | $23.22 | P/E Ratio | 18.40 |
| Prev. Close | $23.37 | Div. (Yield) | N/A (N/A) |
| Daily Range | $22.97 - $23.35 | Volume | 406,874 |
| 52-Wk Range | $17.51 - $25.89 | Avg. Daily Vol. | 0 |
News & Discussion Boards
- Myriad Genetics to Present at the Leerink Swann 2012 Global Healthcare Conference 2/6/2012 4:17:11 PM -
- 4 Upgraded, Undervalued Stocks 2/3/2012 11:47:50 AM -
- Myriad Genetics Inc. Stock Upgraded (MYGN) 2/3/2012 5:00:58 AM -
- Myriad's Prolaris(R) Test Shown to Significantly Predict Biochemical Recurrence Risk After Prostatectomy 2/2/2012 4:17:13 PM -
- Myriad Genetics Outruns Estimates Again 2/1/2012 9:46:04 AM
- Myriad Genetics Outruns Estimates Again 2/1/2012 9:46:04 AM
- Qiagen Posts a Solid 4Q - Analyst Blog 2/1/2012 9:00:01 AM
- Myriad Beats, Raises Guidance - Analyst Blog 2/1/2012 8:00:01 AM
| Subject | Recs | Author | Date |
|---|


